AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Multicenter Ventral Mesh Rectopexy Registry Collaborative

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Antwerp
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this multicenter observational study is to collect data prospectively of patients with pelvic organ prolapse undergoing ventral mesh rectopexy (as well as rectoceles, entero-/sigmoidoceles/ intussusception/ rectal prolapse or combined) by laparoscopy or robotic surgery and to evaluate the longterm functional outcomes. Secondly complications (mesh erosions, recurrence, reoperations) are evaluated. Following main questions will be analysed - other can follow in consultation with the collaborative 1. Is VMR the technique of choice for treatment of rectoceles? Functional results - recurrence - mesh related complications 2. Has a perineal descent an impact on the functional outcome of ventral mesh rectopexy perfored for external rectal prolaps, internal rectal prolaps, rectocele, enterocele, sigmoidcele or combined pelvic organ prolapse?

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of posterior pelvic organ prolaps planned for laparoscopie or robotic ventral mesh rectopexy with or without concomittant surgery. * All patients 18 years or older and are able to complete a written informed conscent are eligble for inclusion. Exclusion Criteria: 1. Inability to complete a written informed conscent 2. Pregnant women 3. No email adress available to send the questionnaires to 4. Language barrier or impossiblity to fill in the questionnaires (at the discretion oft he treating physician)
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

5 sites
UZ Brussel
Brussels, Belgium
University Hospital Antwerp
Edegem, Belgium
AZ Jan Palfijn
Ghent, Belgium
Jessa ziekenhuis
Hasselt, Belgium
AZ Delta Roeselare
Roeselare, Belgium
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy